Update on the management of parapneumonic pleural effusions

L. Teixeira (São Paulo, Brazil)

Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Session: Spanish/Portuguese programme 2021
Session type: Language session
Number: 1275

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Teixeira (São Paulo, Brazil). Update on the management of parapneumonic pleural effusions. Virtual Congress 2021 – Spanish/Portuguese programme 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions?
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011

Predictors of outcome in parapneumonic pleural effusions in children
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001

Management of parapneumonic effusion and empyema in children
Source: Eur Respir J 2002; 20: Suppl. 38, 589s
Year: 2002

Treatment of parapneumonic pleural effusion and empyema: conservative view
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199
Year: 2004

Prognostic features of residual pleural thickening in parapneumonic pleural effusions
Source: Eur Respir J 2003; 21: 952-955
Year: 2003



Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema
Source: Annual Congress 2008 - Pleural effusion
Year: 2008


Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions
Source: Eur Respir J 2002; 19: 320-325
Year: 2002



Parapneumonic effusion and empyema
Source: Respipedia Article
Year: 2017

Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Treatment results of patients with complicated parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 358s
Year: 2002

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001